Peer-reviewedCC BYBiomedicines
Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine–Cisplatin–Temozolomide at a Tertiary Care Center
4 affiliations
- 1Department of Hematology and Oncology, , Cleveland, OH 44106, USA; (W.K.L.D.); (R.R.)
- 2School of Medicine, Cleveland, OH 44106, USA; (M.J.); (F.T.)
- 3Department of Dermatology, School of Medicine, Cleveland, OH 44106, USA;
- 4, Cleveland, OH 44106, USA;
Related
- Symptom burden, Psychosocial Distress, Resilience and Health-Related Quality of Life in Women with Metastatic Breast Cancer Receiving Contemporary Systemic Therapy
- Case Report: Apparent progressive complete mismatch repair protein loss during platinum-based chemotherapy in metastatic rectal neuroendocrine tumour grade 2
- Real‐World Overall Survival With Abiraterone Acetate and Enzalutamide in Patients With Chemotherapy‐Naïve Metastatic Castration‐Resistant Prostate Cancer From the Flatiron Electronic Health Records Database
- A COJEC-chemotherapy resistant model of Th-ALK(F1174L)/MYCN neuroblastoma offers insights into tumour immune evasion and development of the bone marrow metastatic niche
- Cytoreductive cystectomy combined with chemotherapy versus chemotherapy alone in the treatment of metastatic bladder cancer: A retrospective comparative study.
BibTeX
@article{doolittle2026utility,
title = {{Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine–Cisplatin–Temozolomide at a Tertiary Care Center}},
author = {Woo Kyung Lee Doolittle and Rohit Rao and Malena Johnson and Felicia Tejawinata and Akihiro Yoshida and Luke Daniel Rothermel and Ankit Mangla},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701866},
note = {CC BY},
}
RIS
TY - JOUR
TI - Utility of Chemotherapy for Metastatic Melanoma in the Contemporary Era and Experience with Modified Vinblastine–Cisplatin–Temozolomide at a Tertiary Care Center
AU - Woo Kyung Lee Doolittle
AU - Rohit Rao
AU - Malena Johnson
AU - Felicia Tejawinata
AU - Akihiro Yoshida
AU - Luke Daniel Rothermel
AU - Ankit Mangla
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701866
SN - 2227-9059
ER -